Literature DB >> 17391072

Polymorphisms in the CYP19 gene that influence bone mineral density.

José A Riancho1.   

Abstract

Osteoporosis is a prevalent disease with a strong genetic component. Estrogens play a critical role in bone homeostasis. The aromatization of androgenic precursors is the main source of estrogens in men and postmenopausal women. Thus, aromatase is an attractive osteoporosis candidate gene. In this paper the influence of aromatase activity and aromatase gene variants on skeletal homeostasis is reviewed. The results of studies regarding the association between some common polymorphisms of the aromatase gene and bone mineral density and the risk of osteoporotic fractures are described. The mechanisms involved and the potential usefulness of those genetic data in the prevention and management of osteoporosis are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17391072     DOI: 10.2217/14622416.8.4.339

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  5 in total

Review 1.  Basic and clinical aspects of osteoporosis in inflammatory bowel disease.

Authors:  Lorena Rodríguez-Bores; Josué Barahona-Garrido; Jesús K Yamamoto-Furusho
Journal:  World J Gastroenterol       Date:  2007-12-14       Impact factor: 5.742

2.  Association of aromatase and estrogen receptor gene polymorphisms with hip fractures.

Authors:  C Valero; J L Pérez-Castrillón; M T Zarrabeitia; J L Hernández; M A Alonso; J del Pino-Montes; J M Olmos; J González-Macías; J A Riancho
Journal:  Osteoporos Int       Date:  2008-06       Impact factor: 4.507

3.  Aromatase activity and bone loss in men.

Authors:  Daniela Merlotti; Luigi Gennari; Konstantinos Stolakis; Ranuccio Nuti
Journal:  J Osteoporos       Date:  2011-06-24

4.  Pharmacogenomics in osteoporosis: Steps toward personalized medicine.

Authors:  Robert Greene; Shaymaa S Mousa; Mohamed Ardawi; Mohamed Qari; Shaker A Mousa
Journal:  Pharmgenomics Pers Med       Date:  2009-09-10

5.  Genetic polymorphisms are associated with serum levels of sex hormone binding globulin in postmenopausal women.

Authors:  José A Riancho; Carmen Valero; María T Zarrabeitia; María T García-Unzueta; José A Amado; Jesús González-Macías
Journal:  BMC Med Genet       Date:  2008-12-17       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.